Watanabe, M., Boyer, J. L., & Crystal, R. G. (2009). Genetic Delivery of Bevacizumab to Suppress Vascular Endothelial Growth Factor-Induced High-Permeability Pulmonary Edema. Mary Ann Liebert, Inc.
Citação norma ChicagoWatanabe, Masaki, Julie L. Boyer, and Ronald G. Crystal. Genetic Delivery of Bevacizumab to Suppress Vascular Endothelial Growth Factor-Induced High-Permeability Pulmonary Edema. Mary Ann Liebert, Inc, 2009.
MLA CitationWatanabe, Masaki, Julie L. Boyer, and Ronald G. Crystal. Genetic Delivery of Bevacizumab to Suppress Vascular Endothelial Growth Factor-Induced High-Permeability Pulmonary Edema. Mary Ann Liebert, Inc, 2009.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.